Atlas Trials

Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids

Clinical trial NCT01324934 · TERMINATED

Trial details

NCT number
NCT01324934
Sponsor
Neovii Biotech
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Renal Transplant Rejection
Start date
2006-10-01
Primary completion
2011-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.